1. Home
  2. TPCS vs CGTX Comparison

TPCS vs CGTX Comparison

Compare TPCS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

HOLD

Current Price

$5.73

Market Cap

45.1M

Sector

Industrials

ML Signal

HOLD

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$0.99

Market Cap

79.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPCS
CGTX
Founded
1956
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.1M
79.6M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
TPCS
CGTX
Price
$5.73
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
59.3K
382.8K
Earning Date
02-17-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
41.38
62.79
EPS
N/A
N/A
Revenue
$31,644,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.88
$0.55
52 Week High
$6.31
$2.26

Technical Indicators

Market Signals
Indicator
TPCS
CGTX
Relative Strength Index (RSI) 56.25 44.24
Support Level $4.41 $0.93
Resistance Level $5.69 $1.18
Average True Range (ATR) 0.21 0.05
MACD -0.03 -0.00
Stochastic Oscillator 65.30 16.33

Price Performance

Historical Comparison
TPCS
CGTX

About TPCS TechPrecision Corporation

Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: